Literature DB >> 17952467

Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome.

Andrea Calkovska1, Daniela Mokra, Anna Drgova, Ivan Zila, Kamil Javorka.   

Abstract

Surfactant lung lavage is a promising approach in the treatment of meconium aspiration syndrome (MAS). We hypothesise that the enrichment of modified natural surfactant with dextran will enhance meconium clearance from the airspaces during lung lavage and improve lung function in experimental MAS. Human meconium (30 mg/ml; 4 ml/kg) was instilled into the tracheal cannula of anaesthetised and paralysed adult rabbits to induce respiratory failure. The animals were then lavaged with saline (Sal), surfactant without (Surf) and with dextran (Surf+dex). Lung lavage (10 ml/kg in three portions) was performed with diluted surfactant (Curosurf, 10 mg/ml, 100 mg/kg) without or with dextran (3 mg/mg of surfactant phospholipids) or saline and the animals were conventionally ventilated with 100% O(2) for an additional hour. Lung functions were measured prior to and after meconium instillation, and 10, 30 and 60 min after lavage. The recovery of meconium in bronchoalveolar lavage (BAL) fluid was quantified. More meconium solids was recovered in the surfactant-lavaged than in the saline-lavaged groups (Surf: 12.4 +/- 3.9% and Surf+dex: 17.5 +/- 3.5% vs. Sal: 4.8 +/- 1.0%; both P < 0.01). Moreover, more meconium solids was obtained by Curosurf/dextran than by Curosurf-only lavage (P < 0.05). In the Surf group, the values for PaO(2)/FiO(2) were significantly higher than in the controls (at 60 min: 24.5 +/- 4.2 kPa vs.9.1 +/- 2.2 kPa, P < 0.01). An additional increase in oxygenation was seen in the Surf+dex group (at 60 min: 34.2 +/- 8.1 kPa, P vs. Surf group <0.01). The lung-thorax compliance was higher in the Surf+dex group in comparison with the Sal and Surf groups (at 60 min: 9.6 +/- 0.9 vs.7.6 +/- 1.2, P < 0.01 and 8.0 +/- 0.7 ml/kPa/kg, P < 0.05). The enrichment of Curosurf with dextran improves meconium clearance and lung functions in surfactant-lavaged rabbits with meconium aspiration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952467     DOI: 10.1007/s00431-007-0596-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant.

Authors:  Ryota Kakinuma; Hiroshi Shimizu; Yunosuke Ogawa
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

2.  Surfactant lavage for meconium aspiration syndrome: a pilot study.

Authors:  B C Lam; C Y Yeung
Journal:  Pediatrics       Date:  1999-05       Impact factor: 7.124

3.  Modified protocols for surfactant therapy in experimental meconium aspiration syndrome.

Authors:  Katsumi Tashiro; Xiao-Guang Cui; Tsutomu Kobayashi; Tore Curstedt; Bengt Robertson
Journal:  Biol Neonate       Date:  2003

Review 4.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  The surface and transport properties of meconium and reconstituted meconium solutions.

Authors:  B K Rubin; R P Tomkiewicz; M E Patrinos; D Easa
Journal:  Pediatr Res       Date:  1996-12       Impact factor: 3.756

6.  Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract.

Authors:  T Kobayashi; K Ohta; K Tashiro; K Nishizuka; W M Chen; S Ohmura; K Yamamoto
Journal:  J Appl Physiol (1985)       Date:  1999-06

7.  Surfactant tracheobronchial lavage for the management of a rabbit model of meconium aspiration syndrome.

Authors:  B C Lam; C Y Yeung; K H Fu; K Y Wong; F L Chan; N S Tsoi
Journal:  Biol Neonate       Date:  2000

8.  Aggregation of phospholipid vesicles by water-soluble polymers.

Authors:  D Meyuhas; S Nir; D Lichtenberg
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

9.  Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome.

Authors:  C G Cochrane; S D Revak; T A Merritt; I U Schraufstätter; R C Hoch; C Henderson; S Andersson; H Takamori; Z G Oades
Journal:  Pediatr Res       Date:  1998-11       Impact factor: 3.756

10.  Surfactant replacement therapy for meconium aspiration syndrome.

Authors:  R D Findlay; H W Taeusch; F J Walther
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

View more
  8 in total

1.  Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

Authors:  Elena López-Rodríguez; Olga Lucía Ospina; Mercedes Echaide; H William Taeusch; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

Review 2.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

3.  Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.

Authors:  Karen W Lu; Jesús Pérez-Gil; Mercedes Echaide; H William Taeusch
Journal:  Biochim Biophys Acta       Date:  2011-06-27

4.  Protection of Meconium-Induced Lung Epithelial Injury by Protease Inhibitors.

Authors:  C Ota; I Gopallawa; V Ivanov; I H Gewolb; B D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2017-11-20

5.  Meconium Aspiration Syndrome: An Insight.

Authors:  U Raju; V Sondhi; S K Patnaik
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Non-Reflex Defense Mechanisms of Upper Airway Mucosa: Possible Clinical Application.

Authors:  H Pedan; V Janosova; A Hajtman; V Calkovsky
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

7.  Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin.

Authors:  Yuliannis Lugones; Odalys Blanco; Elena López-Rodríguez; Mercedes Echaide; Antonio Cruz; Jesús Pérez-Gil
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

8.  Early cardiac injury in acute respiratory distress syndrome: comparison of two experimental models.

Authors:  P Mikolka; P Kosutova; S Balentova; D Cierny; J Kopincova; M Kolomaznik; M Adamkov; A Calkovska; D Mokra
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.